Signs, Symptoms and Complications

Lawsuits Are Currently Being Filed

Law firms have begun filing suits against the diabetes drug manufacturers. We are currently working with clients who have suffered injury or the loss of a loved one as a result of complications caused by the drugs. We’ll have an initial free consultation to go over medical history and complications, and our staff can look into medical records to find out if you have a case.

• Invokana

• Farxiga

• Xigduo

• Qtern

• Jardiance

• Synjardy

• Steglatro

• Steglujan

• Segluromet 

• Glyxambi

The FDA (Food and Drug Administration) announced that some diabetes medications have been linked to cases of a rare, potentially deadly flesh-eating genital infection. The warning comes after the FDA identified cases of the disease in patients taking a sodium-glucose cotransporter-2 (SGLT2) inhibitor over the course of 5 years, between March 2013 to May 2018. 

The infection that prompted the warning is "necrotizing fasciitis of the perineum," also called "Fournier’s gangrene." The rare infection affects the genital region and has a mortality rate of more than 20 percent, according to a 2012 study published by ISRN Surgery and the National Library of Medicine. 

On August 29th, 2018, the FDA released a list of a dozen drugs that will have to carry a warning of the infection. Among the brand names listed: 

Of the 12 cases studied, all patients required surgery, with some surgeries disfiguring in nature. One patient died, the FDA reported.

The FDA's warning urges patients to seek medical treatment if they experience "tenderness, redness, or swelling of the genitals or the area from the genitals back to the rectum and have a fever above 100.4 F or a general feeling of being unwell."

SGLT2 inhibitors were first approved by the FDA in 2013 and are used with diet and exercise to help lower blood sugar in patients with type 2 diabetes, the FDA says. 

"Untreated, type 2 diabetes can lead to serious problems, including blindness, nerve and kidney damage, and heart disease," according to the FDA.

Questions?  Call Us At:

THIS IS AN ATTORNEY ADVERTISEMENT

Do not stop taking a prescription drug approved by the United States Food and Drug Administration without first consulting a physician.

Aaronson and Rash PLLC Principal Office is in Houston, TX. While this firm maintains joint responsibility, most cases of this type are referred to other attorneys for principal responsibility. Ronald S. Rash is the attorney responsible for the content of this advertisement.  The hiring of a lawyer is an important decision that should not be based solely upon advertisements. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.  This advertisement is not intended for residents of AL, AR, AZ, HI, IN, IA, MS, RI, SC, SD, TN, FL, NY, and KY.  Prior results do not guarantee a similar outcome. Contingent attorneys’ fee refers only to those fees charged by attorneys for their legal services. Such fees are not permitted in all types of cases. Court costs and other additional expenses of legal action usually must be paid by the client. The percentage fee will be computed before or after expenses are deducted from the recovery in accordance with state laws.  Clients are responsible for their own unpaid medical bills. Client may have to pay opposing party’s attorney fees and costs in the event of a loss.  Anyone considering a lawyer should independently investigate the lawyer’s credentials and ability, and not rely upon advertisement or self-proclaimed expertise.